{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T22:22:56Z","timestamp":1694816576214},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["MMW - Fortschritte der Medizin"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1007\/s15006-013-0177-9","type":"journal-article","created":{"date-parts":[[2013,2,28]],"date-time":"2013-02-28T20:19:58Z","timestamp":1362082798000},"page":"59-63","source":"Crossref","is-referenced-by-count":4,"title":["Der Fokus liegt auf der individuellen Risikobewertung"],"prefix":"10.1007","volume":"155","author":[{"given":"Wolfgang W.","family":"Bolten","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Gross","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Brabant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivien","family":"Weck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Labenz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,3,1]]},"reference":[{"key":"177_CR1","unstructured":"Analgesics for Osteoarthritis: An Update of the 2006 Comparative Effectiveness Review. Executive Summary. Im Internet: http:\/\/www.effectivehealthcare.ahrq.gov\/ehc\/products\/180\/805\/Analgesics-Update_executive-summary_20111007.pdf"},{"key":"177_CR2","unstructured":"HeartScore: cardiovascular disease (CVD) risk assessment and managementAufl: European Society of Cardiology. European Association for Cardiovascular Prevention and Rehabilitation Im Internet: http:\/\/www.heartscore.org\/Pages\/welcome.aspx"},{"key":"177_CR3","unstructured":"PROCAM Gesundheitstest f\u00fcr \u00c4rzte. Im Internet: http:\/\/www.assmann-stiftung.de\/stiftungsinstitut\/procam-tests\/procam-gesundheitstest\/ ; Stand: 15.02.2012;"},{"key":"177_CR4","unstructured":"Medical management of adults with osteoarthritis. 2003 Aug (revised 2009 Aug). Southfield (MI): Michigan Quality Improvement Consortium; 2003"},{"key":"177_CR5","unstructured":"Osteoarthritis: the care and management of osteoarthritis in adults (NICE clinical guideline 59). (2008) Im Internet: http:\/\/www.nice.org.uk\/nicemedia\/pdf\/CG59NICEguideline.pdf"},{"key":"177_CR6","unstructured":"Nationale Versorgungsleitlinie Kreuzschmerz. Im Internet: ww.kreuzschmerz.versorgungsleitlinien.de ;"},{"key":"177_CR7","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1161\/CIRCULATIONAHA.106.181424","volume":"115","author":"E.M. Antman","year":"2007","unstructured":"Antman EM, Bennett JS, Daugherty A, et al. Use of nonsteroidal antiinflammatory drugs: an update for clinicians: a scientific statement from the American Heart Association. Circulation 2007; 115: 1634\u20131642","journal-title":"Circulation"},{"key":"177_CR8","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1136\/ebm11033","volume":"16","author":"B. Bluhm","year":"2011","unstructured":"Bluhm B, Green LA. NSAID use associated with increased cardiovascular risk and death, but naproxen appears to be the least harmful. Evid Based Med 2011; 16: 142\u2013143, DOI: 10.1136\/ebm11033","journal-title":"Evid Based Med"},{"key":"177_CR9","unstructured":"Bolten W, Kr\u00fcger K, Reiter S. NSAR \u2014 Aktualisierte Empfehlungen zur Verordnung (Deutsche Gesellschaft f\u00fcr Rheumatologie). (28.10.2009) Im Internet: www.dgrh.de"},{"key":"177_CR10","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1055\/s-2008-1043560","volume":"24","author":"W.W. Bolten","year":"1999","unstructured":"Bolten WW, Lang B, Wagner AV, et al. [Consequences and Costs of NSAID-Induced Gastropathy in Germany] Aktuelle Rheumatologie 1999; 24: 127\u2013134","journal-title":"Aktuelle Rheumatologie"},{"key":"177_CR11","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1136\/ard.2010.128660","volume":"70","author":"G. Burmester","year":"2011","unstructured":"Burmester G, Lanas A, Biasucci L, et al. The appropriate use of non-steroidal anti-inflammatory drugs in rheumatic disease: opinions of a multidisciplinary European expert panel. Ann Rheum Dis 2011; 70: 818\u2013822, DOI: 10.1136\/ard.2010.128660","journal-title":"Ann Rheum Dis"},{"key":"177_CR12","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa003199","volume":"345","author":"F. Catella-Lawson","year":"2001","unstructured":"Catella-Lawson F, Reilly MP, Kapoor SC, et al. Cyclooxygenase Inhibitors and the Antiplatelet Effects of Aspirin. N Engl J Med 2001; 345: 1809\u20131817","journal-title":"N Engl J Med"},{"key":"177_CR13","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1111\/j.1572-0241.2008.02200.x","volume":"103","author":"F.K. Chan","year":"2008","unstructured":"Chan FK, Abraham NS, Scheiman JM, et al. Management of patients on nonsteroidal anti-inflammatory drugs: a clinical practice recommendation from the First International Working Party on Gastrointestinal and Cardiovascular Effects of Nonsteroidal Anti-inflammatory Drugs and Anti-platelet Agents. Am J Gastroenterol 2008; 103: 2908\u20132918, DOI: AJG2200 [pii]10.1111\/j.1572-0241.2008.02200.x [doi]","journal-title":"Am J Gastroenterol"},{"key":"177_CR14","doi-asserted-by":"crossref","unstructured":"Chan FK, Lanas A, Scheiman J, et al. Celecoxib versus omeprazole and diclofenac in patients with osteoarthritis and rheumatoid arthritis (CONDOR): a randomised trial. Lancet 2010; 376: 173\u2013179, DOI: S0140-6736(10)60673-3 [pii]; 10.1016\/S0140-6736(10)60673-3","DOI":"10.1016\/S0140-6736(10)60673-3"},{"key":"177_CR15","doi-asserted-by":"crossref","unstructured":"Chen YF, Jobanputra P, Barton P, et al. Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation. Health Technol Assess 2008; 12: 1\u2013278, iii","DOI":"10.3310\/hta12110"},{"key":"177_CR16","unstructured":"Chou R, McDonagh MS, Nakamoto E, et al, Hrsg. Analgesics for Osteoarthritis: An Update of the 2006 Comparative Effectiveness ReviewAufl. Rockville (MD): Agency for Healthcare Research and Quality (US); 2011 Im Internet: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22091473"},{"key":"177_CR17","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1136\/ard.2010.133488","volume":"70","author":"M. Dougados","year":"2011","unstructured":"Dougados M, Simon P, Braun J, et al. ASAS recommendations for collecting, analysing and reporting NSAID intake in clinical trials\/epidemiological studies in axial spondyloarthritis. Ann Rheum Dis 2011; 70: 249\u2013251, DOI: ard.2010.133488 [pii]; 10.1136\/ard.2010.133488 [doi]","journal-title":"Ann Rheum Dis"},{"key":"177_CR18","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1055\/s-0028-1109855","volume":"47","author":"W. Fischbach","year":"2009","unstructured":"Fischbach W, Malfertheiner P, Hoffmann JC, et al. S3-guideline \"helicobacter pylori and gastroduodenal ulcer disease\" of the German society for digestive and metabolic diseases (DGVS) in cooperation with the German society for hygiene and microbiology, society for pediatric gastroenterology and nutrition e. V., German society for rheumatology, AWMF-registration-no. 021 \/ 001. Z Gastroenterol 2009; 47: 1230\u20131263, DOI: 10.1055\/s-0028-1109855 [doi]","journal-title":"Z Gastroenterol"},{"key":"177_CR19","unstructured":"Haeussler B, H\u00f6er R, Hempel E. Arzneimittel - Atlas 2011. Der Arzneimittelverbrauch in der GKV: Urban & Vogel; 2011"},{"key":"177_CR20","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1136\/bmj.332.7553.1302","volume":"332","author":"P.M. Kearney","year":"2006","unstructured":"Kearney PM, Baigent C, Godwin J, et al. Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials. BMJ 2006; 332: 1302\u20131308","journal-title":"BMJ"},{"key":"177_CR21","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1517\/14740338.5.1.83","volume":"5","author":"M. Maillard","year":"2006","unstructured":"Maillard M, Burnier M. Comparative cardiovascular safety of traditional nonsteroidal anti-inflammatory drugs. Expert Opin Drug Saf 2006; 5: 83\u201394, DOI: 10.1517\/14740338.5.1.83","journal-title":"Expert Opin Drug Saf"},{"key":"177_CR22","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/clpt.2011.45","volume":"89","author":"F. Salvo","year":"2011","unstructured":"Salvo F, Fourrier-Reglat A, Bazin F, et al. Cardiovascular and gastrointestinal safety of NSAIDs: a systematic review of meta-analyses of randomized clinical trials. Clin Pharmacol Ther 2011; 89: 855\u2013866, DOI: 10.1038\/clpt.2011.45","journal-title":"Clin Pharmacol Ther"},{"key":"177_CR23","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1161\/CIRCULATIONAHA.110.004671","volume":"123","author":"A.-M. Schjerning Olsen","year":"2011","unstructured":"Schjerning Olsen A-M. Duration of Treatment With Nonsteroidal Anti-Inflammatory Drugs and Impact on Risk of Death and Recurrent Myocardial Infarction in Patients With Prior Myocardial Infarction A Nationwide Cohort Study. Circulation 2011; 123: 2226\u20132235","journal-title":"Circulation"},{"key":"177_CR24","doi-asserted-by":"crossref","unstructured":"Schneider M, Lelgemann M, Abholz H-H, et al. Intrdisziplin\u00e4re Leitlinie. Management der fr\u00fchen rheumatoiden Arthritis. 3. Aufl. Berlin Heidelberg New York: Springer-Verlag 2011","DOI":"10.1007\/978-3-642-23269-5_2"},{"key":"177_CR25","first-page":"1247","volume":"284","author":"F.E. Silverstein","year":"2000","unstructured":"Silverstein FE, Faich G, Goldstein JL, et al. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study. Journal of the American Medical Association 2000; 284: 1247\u20131255","journal-title":"Celecoxib Long-term Arthritis Safety Study"},{"key":"177_CR26","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.amjmed.2005.09.054","volume":"119","author":"G. Singh","year":"2006","unstructured":"Singh G, Fort JG, Goldstein JL, et al. Celecoxib versus naproxen and diclofenac in osteoarthritis patients: SUCCESS-I Study. Am J Med 2006; 119: 255\u2013266, DOI: S0002-9343(05)00913-7 [pii];10.1016\/j.amjmed.2005.09.054 [doi]","journal-title":"Am J Med"},{"key":"177_CR27","doi-asserted-by":"crossref","first-page":"R153","DOI":"10.1186\/ar2047","volume":"8","author":"G. Singh","year":"2006","unstructured":"Singh G, Wu O, Langhorne P, et al. Risk of acute myocardial infarction with nonselective non-steroidal anti-inflammatory drugs: a meta-analysis. Arthritis Res Ther 2006; 8: R153, DOI: ar2047 [pii]; 10.1186\/ar2047","journal-title":"Arthritis Res Ther"},{"key":"177_CR28","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.amjmed.2005.11.020","volume":"119","author":"B.M. Spiegel","year":"2006","unstructured":"Spiegel BM, Farid M, Dulai GS, et al. Comparing rates of dyspepsia with Coxibs vs NSAID+PPI: a meta-analysis. Am J Med 2006; 119: 448\u2013436","journal-title":"Am J Med"},{"key":"177_CR29","doi-asserted-by":"crossref","first-page":"c7086","DOI":"10.1136\/bmj.c7086","volume":"342","author":"S. Trelle","year":"2011","unstructured":"Trelle S, Reichenbach S, Wandel S, et al. Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis. BMJ 2011; 342: c7086, DOI: 10.1136\/bmj.c7086","journal-title":"BMJ"},{"key":"177_CR30","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1136\/gut.2011.239848","volume":"60","author":"E.M. Soest van","year":"2011","unstructured":"van Soest EM, Valkhoff VE, Mazzaglia G, et al. Suboptimal gastroprotective coverage of NSAID use and the risk of upper gastrointestinal bleeding and ulcers: an observational study using three European databases. Gut 2011; 60: 1650\u20131659, DOI: 10.1136\/gut.2011.239848","journal-title":"Gut"}],"container-title":["MMW - Fortschritte der Medizin"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s15006-013-0177-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s15006-013-0177-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s15006-013-0177-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,9]],"date-time":"2022-02-09T18:06:40Z","timestamp":1644430000000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.springermedizin.de\/doi\/10.1007\/s15006-013-0177-9"}},"subtitle":["Schmerztherapie mit NSAR"],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["177"],"URL":"https:\/\/doi.org\/10.1007\/s15006-013-0177-9","relation":{},"ISSN":["1438-3276"],"issn-type":[{"value":"1438-3276","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]}}}